Related Experiment Video
Updated: May 28, 2026

Functional Characterization of Endogenously Expressed Human RYR1 Variants
Published on: June 9, 2021
[Raynaud's phenomenon, disease or syndrome?]
1Hôpital européen Georges-Pompidou, service de médecine vasculaire et HTA, 75908 Paris Cedex 15. jean-noel.fiessinger@egp.aphp.fr
Raynaud's phenomenon, often benign, can signal underlying connective tissue diseases like scleroderma. Developing screening models is crucial for early diagnosis and appropriate management of this common vascular symptom.
Area of Science:
- Vascular Medicine
- Rheumatology
- Dermatology
Context:
- Raynaud's phenomenon is a prevalent condition, frequently idiopathic and benign.
- However, it can be an early indicator of connective tissue diseases, particularly scleroderma and primary Sjogren's syndrome.
- Localized vasomotor symptoms suggest secondary Raynaud's phenomenon, often linked to arterial disease, including occupational arterial lesions.
Purpose:
- To highlight the necessity of developing effective screening models for Raynaud's phenomenon.
- To differentiate between primary and secondary Raynaud's phenomenon based on symptom presentation.
- To review current and emerging therapeutic strategies for managing Raynaud's phenomenon.
Summary:
- Raynaud's phenomenon requires careful evaluation due to its potential association with systemic diseases.
- Screening models are essential for identifying secondary causes, especially arterial diseases and connective tissue disorders.
- Current treatments include calcium channel blockers and intravenous iloprost for severe cases, with new drugs under investigation.
Impact:
- Improved diagnostic accuracy for secondary Raynaud's phenomenon.
- Timely identification of underlying connective tissue diseases.
- Enhanced management strategies for Raynaud's phenomenon, potentially improving patient outcomes.
Related Concept Videos
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Rheumatic Heart Disease I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Coronary Artery Disease III: Clinical Manifestations
